Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a682860 |
Pregnancy category |
|
Routes of administration |
Intravenous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | n/a |
Protein binding | 65 to 80% |
Metabolism | Hepatic |
Biological half-life | 30 minutes to 1 hour |
Excretion | Renal |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.005.288 |
Chemical and physical data | |
Formula | C16H16N2O6S2 |
Molar mass | 396.44 g/mol |
3D model (Jmol) | |
|
|
|
|
Cefalotin (INN) /ˌsɛfəˈloʊtᵻn/ or cephalothin (USAN) /ˌsɛfəˈloʊθᵻn/ is a first-generation cephalosporin antibiotic. It was the first cephalosporin marketed (1964) and continues to be widely used. It is an intravenously administered agent with a similar antimicrobial spectrum to cefazolin and the oral agent cefalexin. Cefalotin sodium is marketed as Keflin (Lilly) and under other trade names.